
Because rest is not enough
Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.
What’s New…
These stories and more…
Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.
REST IS NOT ENOUGH.

“Historically, we have minimized and ignored concussion injuries. Treatment is focused on the symptoms and not a cure. Back when I was playing sports, “getting your bell rung” and going back into the game was a rite of passage. Yet, if I hurt my knee or ankle, I’d be carried off the field and sent to get an MRI. Today, we know that there can be significant and long-lasting and significant damage after a single concussion. Millions of people continue to suffer for weeks, months, years and even lifetimes as a result of a lack of effective treatments. It is clear that the primary therapy to date is inadequate to address the needs of millions that continue to suffer from daily after sustaining a concussion. Rest is not enough.“
Dr. Michael Wyand
CEO, Oxeia Biopharmaceuticals